U.S. President Donald Trump Said He Is 'not Done' With Putin Despite Being Disappointed
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hans India
22 minutes ago
- Hans India
Trump Says India Adopting a US-Indonesia Style Trade Approach
US President Donald Trump on Tuesday said that India is working on a trade deal with the United States on the same lines as the one he announced recently with Indonesia. The pact will see goods from Indonesia entering the US market subject to a 19 per cent tariff, and those from the US to Indonesia will be exempt from duties, he told reporters in a briefing in Washington. 'India basically is working along that same line. We're going to have access into India,' he said. Indian and US officials are racing to reach a US India Trade deal by an August 1 deadline set by the US President as the two sides seek to avert tariffs in the absence of a pact. Countries, including the EU, have been warned of tariffs as high as 35 per cent from him and this message has been sent to India as well. It was not clear if he was talking of a US Indonesia trade deal exactly the same as that with Indonesia — something that India could find difficult to accept — or a tweaked version with tariffs and concessions dialed down. On those lines, if the US-India bilateral trade deal is similar to US-Indonesia pact, India's exports to the US could face a 19 per cent tariff while US products will come into India duty-free. Donald Trump said he thinks there can be a peace agreement between Russia and Ukraine within 50 days of him negotiating the deal. If this comes to pass, it may help countries like India to escape the brunt of a proposed 100% tariff on energy imports from Russia. Asked if the September 2 deadline was set in stone, he said, '50 days is not a lot of time, it may happen much sooner than that.' Trump said on Tuesday that the US will take 'strong measures' against Russia after it refused to stop fighting in Ukraine. One such move is to impose a 100 per cent secondary levy on countries that continue to import energy from Russia, which indirectly hurts non-combatant countries like India.
Time of India
24 minutes ago
- Time of India
'They had 10,000's of videotape and suddenly don't': Joe Rogan slams DOJ over Epstein files; questions Trump admin's claims on 'no list or footage'
American podcaster Joe Rogan criticised the US Department of Justice (DOJ) and the FBI over the Epstein files controversy, accusing them of lacking transparency in their investigation. He also took aim at the Trump administration's claim that there was never any "client list or footage." Speaking on his latest episode of The Joe Rogan Experience, released Tuesday, Rogan questioned the government's handling of supposed evidence related to Epstein's associates. "They've got videotape and all of a sudden they don't," Rogan said, expressing disbelief over the government's recent claim that there is no client list or incriminating footage. "You had the director of the FBI on this show saying, 'If there was [a videotape], nothing you're looking for is on those tapes,'" Rogan asserted, referring to a previous appearances on his show, including FBI Director Kash Patel, who downplayed the existence of such tapes. Rogan also brought up past statements from Attorney General Pam Bondi, saying, "Like, what? Why'd they say there were thousands of hours of tapes? Why'd they say that? Didn't Pam Bondi say that?" Rogan was reportedly referring to remarks made by Bondi on July 1, just days before the Department of Justice stated there was no "Epstein List" or incriminating footage. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like "밤새 나던 종아리 쥐가 사라졌어요!'', 막힌 혈관 찌꺼기 싹~ 청소한 ''이것'' 대박이네!! 카이스트 건강비결 더 알아보기 Undo At the time, Bondi told reporters that the FBI was reviewing "tens of thousands of videos" involving Epstein, some allegedly containing child pornography. Months earlier, she had suggested there was an "Epstein list" under review, only to later clarify that it was an investigative file, not a list of names, fueling continued speculation. Meanwhile, on Tuesday (local time), US President Donald Trump responded to growing concern among his supporters following the release of a Justice Department and FBI memo last week. The memo stated that Jeffrey Epstein had "no client list" and confirmed he died by suicide in his New York jail cell in 2019. "I don't understand it, why they would be so interested. He's been dead for a long time. He was never a big factor in terms of life. I don't understand what the interest and what the fascination is. I really don't. And the credible information has been given," Trump told reporters. 'These files were made up by Comey, Obama' Again, speaking to reporters outside the White House, Trump said he had received a briefing from Pam Bondi on the DOJ and FBI review. When asked if Bondi "tell you at all that your name appeared in the files?", Trump responded, 'No, no, she's given us just a very quick briefing.' Trump then suggested the investigation was part of a broader political narrative aimed at him. "And in terms of the credibility of the different things that they've seen, and I would say that, you know, these files were made up by Comey, they were made up by Obama, they were made up by the Biden, and you know, we and we went through years of that with the Russia, Russia, Russia hoax, with all of the different things that we had to go through," he added. The renewed attention on the Epstein case has stirred widespread debate online, with Joe Rogan's latest comments adding fuel to the controversy as many continue to question the government's official narrative. This comes after Trump spent months vowing to release all government records related to Epstein and his associates, even promoting a document release titled 'The Epstein Files: Phase 1' in February. However, the files revealed little to no new information. Rogan also appeared skeptical over Trump administration's latest stance, suggesting the US president might be using it to divert attention from his unmet campaign promises related to releasing Epstein-related information, saying "Just bomb Iran and everybody forgets. Everybody forgets about it."
Economic Times
24 minutes ago
- Economic Times
Cooling CPI offers relief, but Fed rate cut may wait until fall: Matt Orton
India plays an important role in tariff development. It will be interesting to see if there is anything related to pharmaceuticals in any sort of tariff agreement, trade deal that is struck between India and the US. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads "So, you have got a decent macro backdrop in the US. We are seeing consumers healthy based on the results we are getting from banks so far and inflation is starting to come down. Granted, all those tariff impacts are not part of that, but it is still much better than we thought it was going to be," says Matt Orton I do not know if this gives the Fed the reason to start to lower rates immediately, but it should be encouraging for investors. Rates in the US can lower. It has always been my expectation that the Fed would start to cut rates once we get into the fall into September and beyond. And what we are seeing is that we are at least the tariffs that have been imposed so far in the US have not been as inflationary as a number of economists have have been able to manage those costs. And if we do end up getting deals, which it seems like President Trump is really pushing to start accelerating the level of deals that are struck, that should be constructive for the inflationary outlook going forward. So, you have got a decent macro backdrop in the US. We are seeing consumers healthy based on the results we are getting from banks so far and inflation is starting to come down. Granted, all those tariff impacts are not part of that, but it is still much better than we thought it was going to India is going to be very specific to sectors most likely. The US probably would like to see energy similar to Indonesia, commitments to energy purchases from the US, that is something that is doable. I also think seeing commitments with respect to defence cooperation that could be something that ends up as part of these deals. But also, with respect to at least openness of a market. It does not mean that the US has to be competitive in the Indian market but at least having the attempt of US company to be able to compete in the automotive space. Tesla launching the Teslas in India. that is a positive step forward that should also give Trump confidence that India is serious about these deals.I do not think they are going to be that competitive in the Indian market, but at least they can be on a similar level playing field and we will see a trade deal that has the spirit of that behind it and that would be very encouraging for the market because that will at least get rid of one of the uncertainty that is out there and then we as investors can really just focus on the fundamentals more at the micro level knowing that the macro backdrop is going to be a little bit more stable going forward at least with respect to potential disruptions at the government pharma tariffs are definitely going to come. Trump has been serious about this. He has talked about it and kind of accelerated his rhetoric towards pharmaceutical tariffs . It is going to be a negative event for the larger pharma companies in the US your Merck, your Pfizer, companies like that. Healthcare has been an area that has been more challenging across the world to invest in.I would say the companies around the world that are most at risk due to the pharmaceutical tariffs are likely going to be the major pharmas in the US and in Europe, that is going to be the concentration of where there can be challenges to the earnings growth setup going plays an important role in tariff development. It will be interesting to see if there is anything related to pharmaceuticals in any sort of tariff agreement, trade deal that is struck between India and the at the end of the day, India plays an important role. You cannot just go cold turkey immediately. There is going to be have some sort of draw down period and that will give cover to some of the Indian pharmaceutical companies that do play a really critical role in the supply chain for pharmaceuticals overall.
